| Introduction: Metabolic syndrome (MetS)
is a group of metabolic abnormalities that
enhance the risk of heart disease and type 2
diabetes. Ghrelin and obestatin are gut
hormones with similar origin that have
pivotal roles in food intake and energy
metabolism. The aim of present study was
to investigate the association between
serum ghrelin/obestatin ratio and the
components of MetS in women.
Materials & Methods: This study was
conducted on the total of 86 women,
including 43 female patients with MetS and
43 healthy women as the control group. The
participants were selected through
convenience sampling method among
women with similar body mass index and
the age range of 30-50 years.
Anthropometric parameters, blood pressure,
fasting serum obestatin, ghrelin,
triglyceride (TG), total cholesterol (TC),
high-density lipoproteins (HDL)
cholesterol, low-density lipoproteins (LDL)
cholesterol, fasting blood sugar (FBS),
insulin, and homeostatic model assessmentinsulin
resistance index (HOMA-IR) were
measured. Moreover, this study
investigated the association between serum
levels of ghrelin/obestatin ratio and MetS
components.
Findings: Serum levels of ghrelin/obestatin
ratio was significantly lower in MetS group
than control(P=0.036). Moreover,
ghrelin/obestatin ratio was positively
associated with serum HDL-C levels
(β=0.273, P=0.016). However, this ratio
was not associated with other measured
variables, including waist circumference,
waist to hip ratio, blood pressure, FBS, TG,
TC, LDL-C, insulin and HOMA-IR
(P>0.05).
Discussion & Conclusions: Considering
lower levels of ghrelin/obestatin ratio in
women with MetS and also positive
association of ghrelin/obestatin ratio and
serum levels of HDL, as an important
component of MetS diagnosis.
Accordingly, it seems the increase in ratio
can lessen the progression of MetS
complications, such as cardio-vascular
disease by HDL increment in women |